Dolby Laboratories, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Dolby Laboratories, Inc. (DLB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $13.13 million for the 12-month period ending 2025-09-26, per its 10-K filed 2025-11-18.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2025-11-18
- Dolby Laboratories, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2013-09-27 was $455.00K.
- Dolby Laboratories, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2013-03-29 was $2.60M.
- Dolby Laboratories, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2012-12-28 was $1.60M.
- Dolby Laboratories, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $13.13M, a 7.70% decline from fiscal 2024.
- Dolby Laboratories, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $14.22M, a 37.44% decline from fiscal 2023.
- Dolby Laboratories, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $22.74M, a 0.65% decline from fiscal 2022.
- Dolby Laboratories, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $22.89M, a 77.74% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2025-09-26 | $13.13M 10-K · filed 2025-11-18 | |||
| 2024-09-27 | $14.22M 10-K · filed 2025-11-18 | |||
| 2023-09-29 | $22.74M 10-K · filed 2025-11-18 | |||
| 2022-09-30 | $22.89M 10-K · filed 2024-11-19 | |||
| 2021-09-24 | $102.81M 10-K · filed 2023-11-17 | |||
| 2020-09-25 | $47.27M 10-K · filed 2022-11-18 | |||
| 2019-09-27 | $33.23M 10-K · filed 2021-11-17 | |||
| 2018-09-28 | $63.97M 10-K · filed 2020-11-16 | |||
| 2017-09-29 | $28.54M 10-K · filed 2019-11-25 | |||
| 2016-09-30 | $27.48M 10-K · filed 2018-11-15 | |||
| 2015-09-25 | $8.55M 10-K · filed 2017-11-16 | |||
| 2014-09-26 | $15.30M 10-K · filed 2016-11-18 | |||
| 2013-09-27 | $455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-24 | $3.78M 10-K · filed 2015-11-24 | ||
| 2013-06-28 | $3.33M 10-Q · filed 2013-07-31 | |||
| 2013-03-29 | $2.60M 10-Q · filed 2013-05-02 | $4.21M derived: sum of 2 quarters · filed 2013-05-02 | ||
| 2012-12-28 | $1.60M 10-Q · filed 2013-02-06 | |||
| 2012-09-28 | $6.19M 10-K · filed 2014-11-18 | |||
| 2011-09-30 | $46.65M 10-K · filed 2013-11-15 | |||
| 2010-09-24 | $79.45M 10-K · filed 2012-11-15 | |||
| 2009-09-25 | $29.52M 10-K · filed 2011-11-23 |